Company sustains high growth and profitability as biomedical industry adoption of solutions continues.
Framingham, MA, January 31, 2004 – clinivation, Inc. today announced record year-end revenue, growth, and profitability results for 2003.
New sales to existing customers were also strong during the year, with additional orders coming from the launch of clinivation Global 2.0 software. Global 2.0 allows companies to build and track all of their medical device submissions and approvals worldwide.
“We thank our customers for enabling us to achieve yet another year of record results, successful product launches, and profitability,” said Joseph Kozikowski, M.D., clinivation’s Founder, Chairman, and Chief Executive Officer. “Our strong rates of growth, fueled by our successful product launches, clearly support the value proposition of our infrastructure and productivity solutions,” he continued.
“Our solutions accelerate our customers up the steepest segment of the medical product value creation curve. In this way, our solutions deliver a tremendous return on investment to our customers,” Dr. Kozikowski remarked.